Pluristem Therapeutics positive results in pre-clinical test of its PLacental eXpanded (PLX) stem cells for the treatment of pulmonary fibrosis. It reduced pulmonary fibrosis (scarring of the lung tissue) and improved lung function in interstitial lung disease (ILD).
http://www.globes.co.il/serveen/globes/docview.asp?did=1000770385&fid=1725